Icon
+91 94997 68112
Login Register

Byetta - (250MCG/ML; Injectable, Subcutaneous)

EXENATIDE SYNTHETIC Astrazeneca
250MCG/ML; Injectable, Subcutaneous
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Yes
**** ** *** *** *** ******* ******* ’*** (*** *, ****), ’*** (*** **, ****), ’*** (*** *, ****), ’***, ’*** (*** **, ****), ’***(*** **, ****), ’*** (*** *, ****) *** *** *********. ***** ****** ***** **** ** **** ******* *** ******* **** ******** ** *** **, **** - ** ******* *** *** *********. ****** *** ****** ** ** ****** ****, ********** *** ******* **** **** ********* ** *** ***** ** ***** **** *** ****** *** ******* ** *** **, ****, ******* **** *** *** ******** *** ******* *** ******** ***** ** *** **********. ******* *** ********** ** ******* **** ****** ** **** ***** ** ****** **** ****** *** **** ****** ******* **** ********. ***** *** *** ********* *** **** ***** *** *** ******** ****** *** *** ** **** ** *** ****** ** ****. *** ** *** *** ***** **** *** ** *** **** ****** *** ***** ** *** *********. **** ******* ** ***** ** ** * *** *********** ******* **** ***** *** ****** ****** ***** ** *** ******* *** *** ******* ***********.
Byetta Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
****** ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** **** **, **** ******* **** ****** **** ********
****** ** \ ** **** *, **** ******* **** ***** ***
  1. *** **, **** : **** ******** *********** ***** *** **** ** *** ****** * ********* *** ***/*.* ** *** *** ***/*.* ** (*** ***/**) **** ******* ’*** (*** *, ****), ’*** (*** **, ****), ’*** (*** *, ****), ’***, ’*** (*** **, ****), ’***(*** **, ****), ’*** (*** *, ****).
  2. *** **, **** : *********** ***** * **** ******* **** ** ******** ***** ** ********.
  3. *** *, **** : *********** **** ****** *** ****** **** ** ** ******* *** ******* **** ******** ** *** **, **** - ** *******.
  4. *** **, **** : ********** *** ******* **** **** ********* ** *** ***** ** ***** **** *** ****** *** ******* ** *** **, ****.
  5. *** **, **** : ********** ******* **** ******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.